SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates
PremiumPress ReleasesSAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates
1M ago
SAB Biotherapeutics founds Clinical Advisory Board for SAB-142 development
Premium
The Fly
SAB Biotherapeutics founds Clinical Advisory Board for SAB-142 development
2M ago
SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes
Premium
Press Releases
SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes
2M ago
SAB Biotherapeutics announces new name, SAB BIO for rebrand focus on type 1
PremiumThe FlySAB Biotherapeutics announces new name, SAB BIO for rebrand focus on type 1
3M ago
SAb Biotherapeutics Rebrands as SAB BIO
Premium
Press Releases
SAb Biotherapeutics Rebrands as SAB BIO
3M ago
SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions
Premium
Press Releases
SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions
3M ago
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
PremiumPress ReleasesFDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
4M ago
SAB Biotherapeutics announces FDA clearance for SAB-142 IND application
Premium
The Fly
SAB Biotherapeutics announces FDA clearance for SAB-142 IND application
4M ago
SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
Premium
Press Releases
SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100